Miho Murakami
- Co-authors
- Norihiro NishimotoYoshihiro OgawaKazuki NakaoTsuneyo MimoriHiroaki MasuzakiSatoshi OzakiMasao TanakaIkuo Kashiwakura
- Topics
- Virus-based gene therapy research (6 papers)Metabolism and Genetic Disorders (4 papers)CAR-T cell therapy research (4 papers)
- Partner nations
- JapanUnited StatesNetherlands
In The Last Decade
Miho Murakami
41 papers receiving 667 citations
Peers
Comparison fields: 5 of 94
- Epidemiology 136
- Molecular Biology 116
- Immunology 94
- Endocrine and Autonomic Systems 91
- Oncology 89
Countries citing papers authored by Miho Murakami
This map shows the geographic impact of Miho Murakami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miho Murakami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miho Murakami more than expected).
Fields of papers citing papers by Miho Murakami
This network shows the impact of papers produced by Miho Murakami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miho Murakami. The network helps show where Miho Murakami may publish in the future.
Co-authorship network of co-authors of Miho Murakami
This figure shows the co-authorship network connecting the top 25 collaborators of Miho Murakami. A scholar is included among the top collaborators of Miho Murakami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miho Murakami. Miho Murakami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | [IL-6 inhibitors prevent bone loss and cartilage degeneration in rheumatoid arthritis]. | 11 |
| 2 | 1 | |
| 3 | 46 | |
| 4 | 4 | |
| 5 | 54 | |
| 6 | 11 | |
| 7 | 20 | |
| 8 | 9 | |
| 9 | 12 | |
| 10 | 38 | |
| 11 | 41 | |
| 12 | [Tocopherol Acetate Reference Standard (Control 021) of National Institute of Health Sciences]. | 2 |
| 13 | [Cholecalciferol Reference Standard (Control 031) of National Institute of Health Sciences]. | 1 |
| 14 | 6 | |
| 15 | 8 | |
| 16 | 13 | |
| 17 | 0 | |
| 18 | 38 | |
| 19 | 1 | |
| 20 | Teprenone a new type of antiulcer drug mechanisms of its action | 1 |
About Miho Murakami
Miho Murakami is a scholar working on Transplantation, Hematology and Clinical Biochemistry, having authored 43 papers that have together received 680 indexed citations. Recurring topics across this work include Virus-based gene therapy research (6 papers), Metabolism and Genetic Disorders (4 papers) and CAR-T cell therapy research (4 papers). The work is most often cited by research in Transplantation (87 citations), Endocrine and Autonomic Systems (91 citations) and Hematology (74 citations). Miho Murakami has collaborated with scholars based in Japan, United States and Netherlands. Frequent co-authors include Norihiro Nishimoto, Yoshihiro Ogawa, Kazuki Nakao, Tsuneyo Mimori, Hiroaki Masuzaki, Satoshi Ozaki, Masao Tanaka, Ikuo Kashiwakura, Hitoshi Tada and Mikinori Kuwabara. Their work appears in journals such as PLoS ONE, CHEST Journal and Physical Chemistry Chemical Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.